Michael A. Posternak

5.6k total citations
64 papers, 4.2k citations indexed

About

Michael A. Posternak is a scholar working on Pharmacology, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, Michael A. Posternak has authored 64 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pharmacology, 36 papers in Psychiatry and Mental health and 31 papers in Experimental and Cognitive Psychology. Recurrent topics in Michael A. Posternak's work include Treatment of Major Depression (53 papers), Schizophrenia research and treatment (23 papers) and Mental Health Research Topics (19 papers). Michael A. Posternak is often cited by papers focused on Treatment of Major Depression (53 papers), Schizophrenia research and treatment (23 papers) and Mental Health Research Topics (19 papers). Michael A. Posternak collaborates with scholars based in United States, Netherlands and Russia. Michael A. Posternak's co-authors include Mark Zimmerman, Iwona Chelminski, Naureen Attiullah, Daniela A. Boerescu, Joseph B. McGlinchey, Jill I. Mattia, Ivan W. Miller, Michael Friedman, Karen E. Kelly and Timothy I. Mueller and has published in prestigious journals such as American Journal of Psychiatry, The British Journal of Psychiatry and Journal of Affective Disorders.

In The Last Decade

Michael A. Posternak

63 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Posternak United States 38 1.9k 1.5k 1.4k 1.1k 735 64 4.2k
Grayson Norquist United States 17 1.9k 1.0× 1.2k 0.8× 935 0.7× 953 0.9× 781 1.1× 42 4.3k
Timothy I. Mueller United States 33 1.8k 0.9× 1.9k 1.2× 1.8k 1.3× 1.6k 1.5× 1.0k 1.4× 54 5.6k
Walter A. Brown United States 43 1.8k 1.0× 1.8k 1.2× 1.1k 0.8× 1.2k 1.1× 638 0.9× 163 5.8k
Jordan F. Karp United States 36 1.5k 0.8× 1.3k 0.8× 1.1k 0.8× 932 0.9× 646 0.9× 179 4.9k
Hannu Koponen Finland 39 791 0.4× 2.0k 1.3× 877 0.6× 1.0k 1.0× 367 0.5× 201 4.9k
Cathryn M. Clary United States 28 1.1k 0.6× 917 0.6× 1.2k 0.8× 1.2k 1.1× 381 0.5× 65 3.1k
Jan Spijker Netherlands 36 1.3k 0.7× 1.0k 0.7× 1.8k 1.3× 1.7k 1.6× 1.3k 1.7× 148 4.9k
Marcia G. Toprac United States 26 995 0.5× 1.8k 1.2× 743 0.5× 949 0.9× 643 0.9× 40 3.3k
Robin B. Jarrett United States 37 1.8k 0.9× 1.3k 0.9× 2.9k 2.1× 2.6k 2.4× 1.0k 1.4× 117 6.0k
Ira M. Lesser United States 41 993 0.5× 2.2k 1.5× 1.1k 0.8× 1.2k 1.1× 769 1.0× 116 5.4k

Countries citing papers authored by Michael A. Posternak

Since Specialization
Citations

This map shows the geographic impact of Michael A. Posternak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Posternak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Posternak more than expected).

Fields of papers citing papers by Michael A. Posternak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Posternak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Posternak. The network helps show where Michael A. Posternak may publish in the future.

Co-authorship network of co-authors of Michael A. Posternak

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Posternak. A scholar is included among the top collaborators of Michael A. Posternak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Posternak. Michael A. Posternak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Posternak, Michael A. & Mark Zimmerman. (2007). Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials. The British Journal of Psychiatry. 190(4). 287–292. 106 indexed citations
2.
Posternak, Michael A., David A. Solomon, Andrew C. Leon, et al.. (2006). The Naturalistic Course of Unipolar Major Depression in the Absence of Somatic Therapy. The Journal of Nervous and Mental Disease. 194(5). 324–329. 74 indexed citations
3.
Zimmerman, Mark, Joseph B. McGlinchey, Michael A. Posternak, et al.. (2006). How Should Remission From Depression Be Defined? The Depressed Patient’s Perspective. American Journal of Psychiatry. 163(1). 148–150. 328 indexed citations
4.
Petersen, Timothy, George I. Papakostas, Michael A. Posternak, et al.. (2005). Empirical Testing of Two Models for Staging Antidepressant Treatment Resistance. Journal of Clinical Psychopharmacology. 25(4). 336–341. 88 indexed citations
5.
Zimmerman, Mark, Michael A. Posternak, Naureen Attiullah, et al.. (2005). Why Isn't Bupropion the Most Frequently Prescribed Antidepressant?. The Journal of Clinical Psychiatry. 66(5). 603–610. 37 indexed citations
6.
Papakostas, George I., Timothy Petersen, Dan V. Iosifescu, et al.. (2005). A Description of Next-Step Switching Versus Augmentation Practices for Outpatients with Treatment-Resistant Major Depressive Disorder Enrolled in an Academic Specialty Clinic. Annals of Clinical Psychiatry. 17(3). 161–165. 12 indexed citations
7.
Solomon, David A., Andrew C. Leon, Timothy I. Mueller, et al.. (2005). Tachyphylaxis in Unipolar Major Depressive Disorder. The Journal of Clinical Psychiatry. 66(3). 283–290. 42 indexed citations
8.
Zimmerman, Mark, Michael A. Posternak, Iwona Chelminski, & Michael Friedman. (2005). Standardized clinical outcome rating scale for depression for use in clinical practice. Depression and Anxiety. 22(1). 36–40. 11 indexed citations
9.
Posternak, Michael A. & Mark Zimmerman. (2005). Dual Reuptake Inhibitors Incur Lower Rates of Tachyphylaxis Than Selective Serotonin Reuptake Inhibitors. The Journal of Clinical Psychiatry. 66(6). 705–707. 42 indexed citations
10.
Posternak, Michael A. & Mark Zimmerman. (2005). Elevated Rates of Psychosis Among Treatment-Seeking Hispanic Patients With Major Depression. The Journal of Nervous and Mental Disease. 193(1). 66–69. 19 indexed citations
11.
Posternak, Michael A. & Mark Zimmerman. (2005). Is There a Delay in the Antidepressant Effect? A Meta-Analysis. The Journal of Clinical Psychiatry. 66(2). 148–158. 175 indexed citations
12.
Coccaro, Emil F., Michael A. Posternak, & Mark Zimmerman. (2005). Prevalence and Features of Intermittent Explosive Disorder in a Clinical Setting. The Journal of Clinical Psychiatry. 66(10). 1221–1227. 60 indexed citations
13.
Zimmerman, Mark, Michael A. Posternak, & Iwona Chelminski. (2004). Implications of using different cut-offs on symptom severity scales to define remission from depression. International Clinical Psychopharmacology. 19(4). 215–220. 44 indexed citations
14.
Zimmerman, Mark, Michael A. Posternak, & Iwona Chelminski. (2004). Defining Remission on the Montgomery-Asberg Depression Rating Scale. The Journal of Clinical Psychiatry. 65(2). 163–168. 95 indexed citations
15.
Posternak, Michael A. & Mark Zimmerman. (2002). Lack of association between seasonality and psychopathology in psychiatric outpatients. Psychiatry Research. 112(3). 187–194. 25 indexed citations
16.
Breen, Robert B., et al.. (2002). An Open-Label Study of Citalopram in the Treatment of Pathological Gambling. The Journal of Clinical Psychiatry. 63(1). 44–48. 85 indexed citations
17.
Posternak, Michael A. & Mark Zimmerman. (2002). The prevalence of atypical features across mood, anxiety, and personality disorders. Comprehensive Psychiatry. 43(4). 253–262. 44 indexed citations
18.
Posternak, Michael A., Mark Zimmerman, & David A. Solomon. (2002). Integrating Outcomes Research Into Clinical Practice. Psychiatric Services. 53(3). 335–336. 25 indexed citations
19.
Posternak, Michael A. & Mark Zimmerman. (2000). Short-Term Spontaneous Improvement Rates in Depressed Outpatients. The Journal of Nervous and Mental Disease. 188(12). 799–804. 18 indexed citations
20.
Leon, Andrew C., David A. Solomon, Timothy I. Mueller, et al.. (2000). A Brief Assessment of Psychosocial Functioning of Subjects with Bipolar I Disorder. The Journal of Nervous and Mental Disease. 188(12). 805–812. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Grayson Norquist Breakdown of academic impact, for papers by Timothy I. Mueller Breakdown of academic impact, for papers by Walter A. Brown Breakdown of academic impact, for papers by Jordan F. Karp Breakdown of academic impact, for papers by Hannu Koponen Breakdown of academic impact, for papers by Cathryn M. Clary Breakdown of academic impact, for papers by Jan Spijker Breakdown of academic impact, for papers by Marcia G. Toprac Breakdown of academic impact, for papers by Robin B. Jarrett Breakdown of academic impact, for papers by Ira M. Lesser
Rankless by CCL
2026